DiaSorin S.p.A

Price Chart

Risk-Adjusted Performance

DiaSorin S.p.A (DSRLF) Price Performance

DiaSorin S.p.A (DSRLF) trades on United States in USD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at $70.76, down 12.80% from the previous close.

Over the past year, DSRLF has traded between a low of $66.65 and a high of $112.30. The stock has lost 29.2% over this period. It is currently 37.0% below its 52-week high.

DiaSorin S.p.A has a market capitalization of $4.29B, with a price-to-earnings ratio of 20.29 and a dividend yield of 1.67%.

About DiaSorin S.p.A

DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, endocrinology, gastrointestinal infections, autoimmunity, hypertension, emergency/sepsis, bone metabolism, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.